原发免疫性血小板减少症骨髓B细胞与浆细胞异常
该研究通过流式细胞术、ELISA和qPCR检测原发免疫性血小板减少症(ITP)患者骨髓B细胞亚群及细胞因子环境,发现总B细胞、初始B细胞及调节性B细胞(Breg)比例降低,自身抗体阳性患者长寿命浆细胞升高,Breg免疫抑制功能减弱,CXCL13-CXCR5和BAFF/APRIL系统过度活化。
要点
- ITP患者骨髓总B细胞、初始B细胞及Breg比例降低,Breg抑制功能减弱。
- 自身抗体阳性ITP患者骨髓长寿命浆细胞频率升高。
- ITP骨髓CXCL13-CXCR5和BAFF/APRIL系统过度活化,呈促炎偏移。
核心结论
- ITP患者骨髓B细胞亚群向促炎表型偏移,提示骨髓B细胞失调参与疾病发生。
研究设计与样本
- 研究采用流式细胞术检测骨髓B细胞亚群及细胞因子/趋化因子受体,ELISA测血浆细胞因子/趋化因子浓度,qPCR测B细胞相关转录因子mRNA水平,体外评估Breg对单核细胞和T细胞的抑制功能,并使用活动性ITP小鼠模型进行体内研究。
主要发现
- 与健康对照相比,ITP患者骨髓总B细胞、初始B细胞比例降低,Breg存在缺陷。
- 自身抗体阳性ITP患者骨髓长寿命浆细胞频率升高。
- ITP患者与健康对照之间浆母细胞或短寿命浆细胞无统计学差异。
- ITP患者骨髓Breg的免疫抑制能力显著弱于健康对照。
- ITP小鼠模型中发现Breg输注可显著减轻血小板减少症,且ITP患者骨髓CXCL13-CXCR5和BAFF/APRIL系统过度活化。
临床怎么用
- 关注ITP患者骨髓B细胞亚群及Breg功能状态,可能有助于理解疾病机制。
- Breg输注在ITP小鼠模型中显示治疗潜力,但尚未转化至临床。
局限性
- 研究未报告样本量、具体数值及P值等统计细节。
- Breg输注的疗效仅见于活动性ITP小鼠模型,人体证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary immune thrombocytopenia (ITP) is an autoantibody-mediated hemorrhagic disorder in which B cells play an essential role. Previous studies have focused on peripheral blood (PB), but B cells in bone marrow (BM) have not been well characterized. We aimed to explore the profile of B-cell subsets and their cytokine environments in the BM of patients with ITP to further clarify the pathogenesis of the disease. B-cell subpopulations and their cytokine/chemokine receptors were detected by using flow cytometry. Plasma concentrations of cytokines/chemokines were measured by using enzyme-linked immunosorbent assay. Messenger RNA levels of B cell-related transcription factors were determined by using quantitative polymerase chain reaction. Regulatory B cell (Breg) function was assessed by quantifying their inhibitory effects on monocytes and T cells in vitro. Decreased proportions of total B cells, naive B cells, and defective Bregs were observed in patients with ITP compared with healthy controls (HCs), whereas an elevated frequency of long-lived plasma cells was found in BM of autoantibody-positive patients. No statistical difference was observed in plasmablasts or in short-lived plasma cells between patients with ITP and HCs. The immunosuppressive capacity of BM Bregs from patients with ITP was considerably weaker than HCs. An in vivo study using an active ITP murine model revealed that Breg transfusion could significantly alleviate thrombocytopenia. Moreover, overactivation of CXCL13-CXCR5 and BAFF/APRIL systems were found in ITP patient BM. Taken together, B-cell subsets in BM were skewed toward a proinflammatory profile in patients with ITP, suggesting the involvement of dysregulated BM B cells in the development of the disease.
引用
- Yu TS, Wang HY, Zhao YJ, et al. Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood Adv. 2021. PMID: 34507351. doi:10.1182/bloodadvances.2020003860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。